跳至主要内容
临床试验/ACTRN12610000364077
ACTRN12610000364077撤回未知

Contribution of the level of protein hydrolysis to the effects of intraduodenal protein, on antropyloroduodenal motility, gut hormone release and sensations of appetite in lean and obese males.

Christine Feinle-Bisset0 个研究点目标入组 32 人开始时间: 2010年5月7日最近更新:
适应症

试验速览

阶段
未知
状态
撤回
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
Male

入选标准

  • non-obese with a Body Mass Index (BMI) of 18-25 kg/m2 and obese with a BMI of 27-35 kg/m2
  • Weight stable (<5% fluctuation in body weight in previous 3 months)

排除标准

  • Significant gastrointestinal symptoms, disease or surgery.
  • Use of prescribed or non-prescribed medications (including vitamins and herbal suppliments) which may affect energy metabolism, gastrointestinal function, body weight or appetite (eg domperidone and cisapride, anticholinergic drugs (eg atropine), metoclopramide, erythromycin, hyoscine, orlistat, green tea extracts, Astragalus, St Johns Wort etc)

研究者

相似试验

Contribution of the level of protein hydrolysis to... | 临床试验